All Posts: research
-
Georgetown Receives $27.5 Million to Address HIV/AIDS in Haiti
The U.S. Centers for Disease Control and Prevention and the President’s Emergency Plan for AIDS Relief have awarded Georgetown $27.5 million to expand its ongoing work in Haiti to address HIV/AIDS. The funding builds on the work of the Center for Global Health Practice and Impact to provide medical care for Haitians living with HIV, particularly those who have dropped from treatment, and reduce barriers to treatment.
Category: GUMC Stories
-
Competitive Cancer Research Internship Program Offers Rewarding Experiences for Undergraduates
This year, 10 rising sophomores, juniors and seniors from colleges and universities across the country participated in the 10-week full-time Diversity in Cancer Research Undergraduate Internship Program, which affords students the opportunity to get a broad view of what cancer research is.
Category: GUMC Stories
-
H5 Influenza Vaccines: What Needs To Be Done To Reduce the Risk of a Pandemic
As the global threat of H5N1 influenza looms, with outbreaks across species and continents, including the U.S., three international vaccine and public health experts say it is time to fully resource and support a robust strategy to address this and future potential pandemic influenza threats, including to consider voluntary vaccination for those now at exposure risk.
Category: News Release
-
For This Medical Student, Her Cancer Research Is for Her Little Sister
Ritu Amarnani (M’27), a second-year medical student, spent this summer researching cancer care at Georgetown’s Lombardi Comprehensive Cancer Center. She turned her career focus toward medicine after her younger sister’s cancer diagnosis and death.
Category: GUMC Stories
-
Identifying ‘Stealth’ Sources of Saturated Fat, Added Sugar in the Diet
A newly compiled list of foods and drinks commonly consumed in the United States hints at why many adults unknowingly overdo it on saturated fat and added sugar in their daily diet, a new study by a team including Georgetown Lombardi researchers suggests.
Category: GUMC Stories
-
ISPY2: A Unique, Flexible Breast Cancer Trial for Modern Times
The ISPY2 breast cancer clinical trial is a unique phase 2 study that offers a broad range of treatment options for patients with locally advanced breast cancer.
Category: GUMC Stories
-
Strengthening Global Regulatory Capacity for Equitable Access to Vaccines in Public Health Emergencies
Three high-impact steps could be taken by global health leaders to reshape the global regulatory framework and help address the pressing need for equitable access to diagnostics, therapeutics and vaccines during public health emergencies, say a Georgetown global health law expert and a medical student.
Category: News Release
-
Pharmacology & Physiology Student is Georgetown’s First HHMI Gilliam Fellow
In July 2024, Pharmacology & Physiology doctoral student Lindsey Russ became Georgetown University’s first recipient of the Howard Hughes Medical Institute (HHMI) Gilliam Fellowship, which “invests in graduate trainees who are committed to advancing equity and inclusion in science and empowers them as future science leaders.”
Category: GUMC Stories
-
Surgeon and Basic Scientists Partner to Develop New Way to Suss Out Early Problems in Liver Transplantation
A unique collaboration between basic scientists at Georgetown University Medical Center and a transplant surgeon at MedStar Health could change how and when problems are identified with liver transplants, leading to expedited treatment and significantly reducing the need for additional testing.
Category: GUMC Stories
-
Georgetown Global Health and Cancer Researchers Tackle Public Health Challenge in Eswatini
A collaboration between researchers at Georgetown’s Lombardi Comprehensive Cancer Center and a Georgetown global health team in Eswatini aims to address a significant public health challenge: preventing cervical cancer.
Category: GUMC Stories